Bone-marrow mesenchymal stem cell transplantation to treat diabetic nephropathy in tree shrews

Cell Biochemistry and Function

Volumn 32, Issue 5, 2014, Pages 453-463

  Pan, Xing Hua ^a   Yang, Xiao Yan ^a,b   Yao, Xiang ^a   Sun, Xiao Mei ^c   Zhu, Lu ^a   Wang, Jin Xiang ^a   Pang, Rong Qing ^a   Cai, Xue Min ^a   Dai, Jie Jie ^c   Ruan, Guang Ping ^a  

^a KUNMING GENERAL HOSPITAL   (China)

^b KUNMING MEDICAL UNIVERSITY   (China)

^c INSTITUTE OF MEDICAL BIOLOGY   (China)

Author keywords

Bone marrow mesenchymal stem cells; DAPI; Diabetic nephropathy; Transplantation; Tree shrews

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; CHOLESTEROL; CREATININE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; NITROGEN; TRIACYLGLYCEROL; UREA; ADVANCED GLYCATION END PRODUCT; GLUCOSE BLOOD LEVEL; STREPTOZOCIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW MESENCHYMAL STEM CELL TRANSPLANTATION; CELL STRUCTURE; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DISORDERS OF LIPID METABOLISM; DYSLIPIDEMIA; GLOMERULUS CAPILLARY; GLUCOSE BLOOD LEVEL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOGLOBIN BLOOD LEVEL; HYPERPHAGIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; KIDNEY DISEASE; KIDNEY PARENCHYMA; LIPID DIET; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NECROSIS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET; POLYDIPSIA; POLYURIA; PRIORITY JOURNAL; PROTEINURIA; SCANDENTIA; SUGAR INTAKE; TISSUE STRUCTURE; TRIACYLGLYCEROL BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; URINE VOLUME; WEIGHT REDUCTION; ANALYSIS; ANIMAL; BLOOD; BONE MARROW CELL; CHEMICALLY INDUCED; CYTOLOGY; DIABETIC NEPHROPATHIES; DISEASE MODEL; GLOMERULUS FILTRATION RATE; KIDNEY; MESENCHYMAL STROMA CELL; PANCREAS; PATHOLOGY; TOXICITY;

TUPAIIDAE;

ANIMALS; BLOOD GLUCOSE; BLOOD UREA NITROGEN; BONE MARROW CELLS; CHOLESTEROL; CREATININE; DIABETIC NEPHROPATHIES; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; GLOMERULAR FILTRATION RATE; GLYCOSYLATION END PRODUCTS, ADVANCED; INSULIN; KIDNEY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; PANCREAS; STREPTOZOCIN; TRIGLYCERIDES; TUPAIIDAE;

EID: 84903787842     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.3037     Document Type: Article

References (49)

1. Franckhauser S, Munoz S, Elias I, Ferre T, Bosch F. Adipose overexpression of phosphoenolpyruvate carboxykinase leads to high susceptibility to diet-induced insulin resistance and obesity. Diabetes 2006; 55: 273-280.
2. Sumiyoshi M, Sakanaka M, Kimura Y. Chronic intake of high-fat and high-sucrose diets differentially affects glucose intolerance in mice. J Nutr 2006; 136: 582-587.
3. Ye JM, Doyle PJ, Iglesias MA, et al. Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: comparison with PPAR-gamma activation. Diabetes 2001; 50: 411-417.
4. Gruden G, Thomas S, Burt D, et al. Mechanical stretch induces vascular permeability factor in human mesangial cells: mechanisms of signal transduction. Proc Natl Acad Sci U S A 1997; 94: 12112-12116.
5. Xuan L. Diabetic ophthahnopathy complication model induced by streptozotocin-complete Freund's adjuvant. Chin J Phramacol Toxicol 2005; 19: 146-150.
6. Cao J, Yang EB, Su JJ, Li Y, Chow P. The tree shrews: adjuncts and alternatives to primates as models for biomedical research. J Med Primatol 2003; 32: 123-130.
7. Fan Y, Huang ZY, Cao CC, et al. Genome of the Chinese tree shrew. Nat Commun 2013; 4: 1426.
8. Li R, Xu W, Wang Z, et al. Proteomic characteristics of the liver and skeletal muscle in the Chinese tree shrew (Tupaia belangeri chinensis). Protein Cell 2012; 3: 691-700.
9. Wang J, Zhou QX, Lv LB, Xu L, Yang YX. A depression model of social defeat etiology using tree shrews. Dongwuxue Yanjiu 2012; 33: 92-98.
10. Walter E, Keist R, Niederost B, Pult I, Blum HE. Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo. Hepatology 1996; 24: 1-5.
11. Fuchs E. Social stress in tree shrews as an animal model of depression: an example of a behavioral model of a CNS disorder. CNS Spectr 2005; 10: 182-190.
12. Rabb GB, Getty RE, Williamson WM, Lombard LS. Spontaneous diabetes mellitus in tree shrews, Urogale everetti. Diabetes 1966; 15: 327-330.
13. Ishiko S, Yoshida A, Mori F, et al. Early ocular changes in a tree shrew model of diabetes. Nihon Ganka Gakkai Zasshi 1997; 101: 19-23.
14. Xian SHS, Su J, Qin Y, Ou C, Luo Z, Wei M. A study on experimental diabetes animal models in tree shrews induced by streptozotocin. J Guangxi Med Univ 2000; 17: 945-948.
15. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147.
16. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41-49.
17. da Silva ML, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 2006; 119: 2204-2213.
18. Sun Y, Chen L, Hou XG, et al. Differentiation of bone marrow-derived mesenchymal stem cells from diabetic patients into insulin-producing cells in vitro. Chin Med J (Engl) 2007; 120: 771-776.
19. Timper K, Seboek D, Eberhardt M, et al. Human adipose tissue-derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells. Biochem Biophys Res Commun 2006; 341: 1135-1140.
20. Gao F, Wu DQ, Hu YH, et al. In vitro cultivation of islet-like cell clusters from human umbilical cord blood-derived mesenchymal stem cells. Transl Res 2008; 151: 293-302.
21. Chao KC, Chao KF, Fu YS, Liu SH. Islet-like clusters derived from mesenchymal stem cells in Wharton's Jelly of the human umbilical cord for transplantation to control type 1 diabetes. PLoS One 2008; 3: e1451.
22. Urban VS, Kiss J, Kovacs J, et al. Mesenchymal stem cells cooperate with bone marrow cells in therapy of diabetes. Stem Cells 2008; 26: 244-253.
23. Wu XH, Liu CP, Xu KF, et al. Reversal of hyperglycemia in diabetic rats by portal vein transplantation of islet-like cells generated from bone marrow mesenchymal stem cells. World J Gastroenterol 2007; 13: 3342-3349.
24. Vojtassak J, Danisovic L, Kubes M, et al. Autologous biograft and mesenchymal stem cells in treatment of the diabetic foot. Neuro Endocrinol Lett 2006; 27(Suppl 2): 134-137.
25. Zhang N, Li J, Luo R, Jiang J, Wang JA. Bone marrow mesenchymal stem cells induce angiogenesis and attenuate the remodeling of diabetic cardiomyopathy. Exp Clin Endocrinol Diabetes 2008; 116: 104-111.
26. Abdel Aziz MT, El-Asmar MF, Haidara M, et al. Effect of bone marrow-derived mesenchymal stem cells on cardiovascular complications in diabetic rats. Med Sci Monit 2008; 14: BR249-255.
27. Li JH, Zhang N, Wang JA. Improved anti-apoptotic and anti-remodeling potency of bone marrow mesenchymal stem cells by anoxic pre-conditioning in diabetic cardiomyopathy. J Endocrinol Invest 2008; 31: 103-110.
28. Lee RH, Seo MJ, Reger RL, et al. Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc Natl Acad Sci U S A 2006; 103: 17438-17443.
29. Ezquer FE, Ezquer ME, Parrau DB, et al. Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice. Biol Blood Marrow Transplant 2008; 14: 631-640.
30. Bianco P, Robey PG, Simmons PJ. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2008; 2: 313-319.
31. Elliot OS, Elliot MW, Lisco H. Breast cancer in a tree shrew (Tupaia glis). Nature 1966; 211: 1105.
32. Wu X, Chang Q, Zhang Y, et al. Relationships between body weight, fasting blood glucose concentration, sex and age in tree shrews (Tupaia belangeri chinensis). J Anim Physiol Anim Nutr (Berl) 2013; 97: 1179-1188.
33. Chiasson JL, Rabasa-Lhoret R. Prevention of type 2 diabetes: insulin resistance and beta-cell function. Diabetes 2004; 53(Suppl 3): S34-38.
34. Nakata M, Okada T, Ozawa K, Yada T. Resistin induces insulin resistance in pancreatic islets to impair glucose-induced insulin release. Biochem Biophys Res Commun 2007; 353: 1046-1051.
35. Donath MY, Ehses JA. Type 1, type 1.5, and type 2 diabetes: NOD the diabetes we thought it was. Proc Natl Acad Sci U S A 2006; 103: 12217-12218.
36. Togel F, Hu Z, Weiss K, et al. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol 2005; 289: F31-42.
37. Morigi M, Introna M, Imberti B, et al. Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice. Stem Cells 2008; 26: 2075-2082.
38. Imberti B, Morigi M, Tomasoni S, et al. Insulin-like growth factor-1 sustains stem cell mediated renal repair. J Am Soc Nephrol 2007; 18: 2921-2928.
39. Bruno S, Grange C, Deregibus MC, et al. Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol 2009; 20: 1053-1067.
40. Morigi M, Imberti B, Zoja C, et al. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J Am Soc Nephrol 2004; 15: 1794-1804.
41. Herrera MB, Bussolati B, Bruno S, et al. Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. Int J Mol Med 2004; 14: 1035-1041.
42. Togel F, Weiss K, Yang Y, et al. Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am J Physiol Renal Physiol 2007; 292: F1626-1635.
43. Chen J, Li H, Addabbo F, et al. Adoptive transfer of syngeneic bone marrow-derived cells in mice with obesity-induced diabetes: selenoorganic antioxidant ebselen restores stem cell competence. Am J Pathol 2009; 174: 701-711.
44. Ezquer F, Ezquer M, Simon V, et al. Endovenous administration of bone-marrow-derived multipotent mesenchymal stromal cells prevents renal failure in diabetic mice. Biol Blood Marrow Transplant 2009; 15: 1354-1365.
45. Zhou H, Tian HM, Long Y, et al. Mesenchymal stem cells transplantation mildly ameliorates experimental diabetic nephropathy in rats. Chin Med J (Engl) 2009; 122: 2573-2579.
46. Iwasaki M, Adachi Y, Minamino K, et al. Mobilization of bone marrow cells by G-CSF rescues mice from cisplatin-induced renal failure, and M-CSF enhances the effects of G-CSF. J Am Soc Nephrol 2005; 16: 658-666.
47. Ende N, Chen R, Reddi AS. Transplantation of human umbilical cord blood cells improves glycemia and glomerular hypertrophy in type 2 diabetic mice. Biochem Biophys Res Commun 2004; 321: 168-171.
48. Lange C, Togel F, Ittrich H, et al. Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats. Kidney Int 2005; 68: 1613-1617.
49. Kunter U, Rong S, Djuric Z, et al. Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis. J Am Soc Nephrol 2006; 17: 2202-2212.